Aether Industries Q4 FY22 revenue up 26.8%; Profit up 13.8%
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
Subscribe To Our Newsletter & Stay Updated